| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/19/2008 | EP1899478A2 Improving antibody expression using vectors containing insulator elements |
| 03/19/2008 | EP1899477A2 An integrated approach for generating multidomain protein therapeutics |
| 03/19/2008 | EP1899476A2 Production of cellulase |
| 03/19/2008 | EP1899475A2 A composition for wound healing and use thereof |
| 03/19/2008 | EP1899474A1 Use of lepa for improving the accuracy of protein synthesis in vitro |
| 03/19/2008 | EP1899364A2 Compositions and methods for immunomodulation in an organism |
| 03/19/2008 | EP1700916B1 Novel centromeric protein shugoshin |
| 03/19/2008 | EP1455943B1 Device and method for processing biological or chemical substances or substance mixtures thereof |
| 03/19/2008 | EP1428880B1 Kidney-specific urate transporter and gene thereof |
| 03/19/2008 | EP1306431B1 Tumor antigen |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | EP0979279B1 Hemoglobin mutants with reduced nitric oxide scavenging |
| 03/19/2008 | EP0929564B1 High level expression of proteins |
| 03/19/2008 | CN101146818A Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 03/19/2008 | CN101144095A Method for producing ethanol by starch material |
| 03/19/2008 | CN101144080A Method for preparing recombination human VIP-Humanin fusion protein |
| 03/19/2008 | CN101143896A Bacillus subtilis antibiotic peptide fengycin homologue and preparation method thereof |
| 03/19/2008 | CN101143892A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/18/2008 | US7345160 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits |
| 03/18/2008 | US7345157 For analyzing the localization or dynamics of a protein in cells, for analyzing a physiologically active substance |
| 03/18/2008 | US7345156 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/18/2008 | US7345152 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345149 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine |
| 03/18/2008 | US7345147 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 03/18/2008 | US7345146 PRO1271 Polypeptides |
| 03/18/2008 | US7344880 Nucleotide sequences coding polypeptide for use in the treatment of immunological disorders |
| 03/18/2008 | US7344871 Recombinant hydrolase for use in conversion of pl ant biomass into ethanol; enhancing laundering vdetergents |
| 03/18/2008 | US7344870 3-phosphoinositide-dependent protein kinase |
| 03/18/2008 | US7344863 Methods for producing polypeptides through enhanced synthesis of encoding nucleic acid molecules |
| 03/18/2008 | US7344862 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 03/18/2008 | US7344860 Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v |
| 03/18/2008 | US7344859 Chimeric g-protein coupled receptor for use as tool in high throughput assays which screen/identify modulators of sweet taste; artificial sweetners; enhancing consumability/flavor of animal feeds |
| 03/18/2008 | US7344857 Comprises nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development |
| 03/18/2008 | US7344856 Method of controlling cleavage by OmpT protease |
| 03/18/2008 | US7344844 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 03/18/2008 | US7344838 Gene encoding brain specific membrane protein |
| 03/18/2008 | US7344719 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 03/18/2008 | US7344714 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 03/18/2008 | US7344713 Decreased fat absorption with an anti-lipase antibody |
| 03/18/2008 | CA2400735C Process for producing peptides by using in vitro transcription/translation system |
| 03/18/2008 | CA2383554C Methods for the detection, analysis and isolation of nascent proteins |
| 03/18/2008 | CA2320430C Recombinant mistletoe lectins |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/18/2008 | CA2181073C Tissue-specific enhancer active in prostate |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2089735C Ryegrass pollen allergen |
| 03/14/2008 | CA2568354A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/13/2008 | WO2008030614A2 Suppressor trna transcription in vertebrate cells |
| 03/13/2008 | WO2008030613A2 Hybrid suppressor trna for vertebrate cells |
| 03/13/2008 | WO2008030612A2 Site specific incorporation of non-natural amino acids by vertebrate cells |
| 03/13/2008 | WO2007136752A3 Erythropoietin compositions |
| 03/13/2008 | WO2007092314A3 Esterases and related nucleic acids and methods |
| 03/13/2008 | WO2005010153A3 Antibodies and uses thereof |
| 03/13/2008 | US20080066195 Taste Receptors of the T1r Family Form Domestic Cat |
| 03/13/2008 | US20080064862 Recombinant chicken comprising vector which express shell protein in oviducts; enhancing egg hardness |
| 03/13/2008 | US20080064859 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 03/13/2008 | US20080064857 Immunoglobulin for use in diagnosis, prevention and treatment of metabolic disorders of pancreas |
| 03/13/2008 | US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder |
| 03/13/2008 | US20080064741 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064644 Serum-Free Cell Culture Medium for Mammalian Cells |
| 03/13/2008 | US20080064630 Prolonged circulation time; combined with such as human growth hormone or fragments; nucleic acid constructs, vectors, host cells; culturing and harvesting |
| 03/13/2008 | US20080064107 Use of multiple transformation enhancer sequences to improve plant transformation efficiency |
| 03/13/2008 | US20080064097 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080064068 Method of Production of Recombinant Proteins in Eukaryote Cells |
| 03/13/2008 | US20080064067 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 03/13/2008 | US20080064066 Modified human granulocyte-colony stimulating factor and process for producing same |
| 03/13/2008 | US20080064065 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 03/13/2008 | US20080064064 Mannanases |
| 03/13/2008 | US20080064063 Compositions and methods for producing steviol and steviol glycosides |
| 03/13/2008 | US20080064062 Microorganism strain for producing recombinant proteins |
| 03/13/2008 | US20080064061 Yeast Promoter |
| 03/13/2008 | US20080064060 Major histocompatibility complex proteins for use in tissue targeted therapy of tumor antigens; diagnosing organ transplant rejection |
| 03/13/2008 | US20080064059 In Vivo Site-Specific Incorporation of N-Acetyl-Galactosamine Amino Acids in Eubacteria |
| 03/13/2008 | US20080063780 Methods and products related to the transfer of molecules from blood to the mammary gland |
| 03/13/2008 | US20080063776 Carboxypeptidase of cocoa |
| 03/13/2008 | US20080063667 ProDer P 1 Expressed in a Prokaryotic Cell |
| 03/13/2008 | US20080063641 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment |
| 03/13/2008 | US20080063635 Stabilized Human Igg4 Antibodies |
| 03/13/2008 | US20080063623 adjuvants comprising proteins, polynucleotides, or genetic vectors and carriers |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | CA2663047A1 Therapeutic elastin-like polypeptide (elp) fusion proteins |
| 03/13/2008 | CA2662755A1 Suppressor trna transcription in vertebrate cells |
| 03/13/2008 | CA2662753A1 Hybrid suppressor trna for vertebrate cells |
| 03/13/2008 | CA2662752A1 Site specific incorporation of non-natural amino acids by vertebrate cells |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/12/2008 | EP1897951A2 Composition and methods for producing steviol and steviol glycosides |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897942A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1896605A2 Stimulation of pancreatic b cell proliferation |
| 03/12/2008 | EP1896603A2 Biosynthetic process for the preparation of gallidermin |
| 03/12/2008 | EP1896590A2 Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| 03/12/2008 | EP1896588A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
| 03/12/2008 | EP1896582A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |